Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.

Ann Surg Oncol · 2019 · PMC6864028 · PMID 31452052

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although our cohort showed the RCB as highly significant, stable, prognostic parameter, it cannot serve as confirmation for long-term prognosis, particularly for patients with hormone receptor-positive disease.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.